Breaking News: Myriad Genetics Acquires Gateway Genomics | Learn More
Title: Transforming patient care with precision risk assessment.
Objectives: Demonstrate the clinical, financial, and operational impact of a high-risk genetics program
Speaker: Dr. Amanda Squires, MD, Vista Radiology, Knoxville, TN
Date/Time: Mon 5/16, 7pm-8:30pm
Myriad needs the contact information you provide to us to contact you about our products and services. You may
unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your
Help patients get ahead of cancer with our hereditary cancer test. View MyRisk™ gene panel table.
Identify couples at risk to pass down serious, prevalent, clinically-actionable inherited conditions.
Get reliable results the first time with noninvasive prenatal screening.
For more than 30 years now, scientists at Myriad Genetics have been finding creative ways to coax new information out of human genes. The love for exploring th...
Throughout March we’re celebrating Women’s History Month, a recognition of the countless contributions women have made here in the U.S. and around the worl...
Myriad Genetics was honored to participate in one of the most important conferences for Maternal Fetal Medicine specialists and other medical providers focused...
In March 2022, Myriad Genetics was named one of the World’s Most Innovative Companies by Fast Company. Since 2008, Fast Company’s Most Innovative Comp...